Archive for November, 2010
« Previous EntriesWill I see you Wednesday night at the Welder Center? – Victoria Advocate (blog)
Tuesday, November 30th, 2010
Will I see you Wednesday night at the Welder Center?Victoria Advocate (blog)When not shooting video of high school football, Drew discovered a much more serious story — about three families living with amyotrophic lateral sclerosis …
Cytokinetics to Present at Canaccord Genuity 5th Annual Cardiovascular … – MarketWatch (press release)
Tuesday, November 30th, 2010Cytokinetics to Present at Canaccord Genuity 5th Annual Cardiovascular …MarketWatch (press release)… and has been granted orphan-drug designation by the US Food and Drug Administration for the potential treatment of amyotrophic lateral sclerosis. …
Knopp Biosciences Announces Hiring of Suresh Khemani as VP of Commercial and … – PharmaLive (press release) (subscription)
Tuesday, November 30th, 2010Knopp Biosciences Announces Hiring of Suresh Khemani as VP of Commercial and …PharmaLive (press release) (subscription)Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease and motor neuron disease, is a universally and rapidly fatal neurodegenerative disorder …and more »
Knopp Biosciences Announces Hiring of Suresh Khemani as VP of Commercial and … – Trading Markets (press release)
Tuesday, November 30th, 2010Knopp Biosciences Announces Hiring of Suresh Khemani as VP of Commercial and …Trading Markets (press release)Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease and motor neuron disease, is a universally and rapidly fatal neurodegenerative disorder …and more »
Knopp Biosciences Announces Hiring of Suresh Khemani as VP of Commercial and … – MarketWatch (press release)
Tuesday, November 30th, 2010Knopp Biosciences Announces Hiring of Suresh Khemani as VP of Commercial and …MarketWatch (press release)Amyotrophic lateral sclerosis, also known as Lou Gehrig's disease and motor neuron disease, is a universally and rapidly fatal neurodegenerative disorder …and more »
AVANIR Pharmaceuticals Announces Fiscal 2010 Fourth Quarter and Full Year … – PR Newswire (press release)
Tuesday, November 30th, 2010AVANIR Pharmaceuticals Announces Fiscal 2010 Fourth Quarter and Full Year …PR Newswire (press release)Studies to support the effectiveness of NUEDEXTA were performed in patients with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). …and more »
Neuraltus Pharmaceuticals Reports Clinical Results from Phase 1 NP001 Study in … – PR Newswire (press release)
Tuesday, November 30th, 2010Neuraltus Pharmaceuticals Reports Clinical Results from Phase 1 NP001 Study in …PR Newswire (press release)Neuraltus has three clinical-stage programs in its development pipeline, including potential treatments for Amyotrophic Lateral Sclerosis (ALS, …and more »
SGMO rises more than 10% – EFPR (press release)
Tuesday, November 30th, 2010SGMO rises more than 10%EFPR (press release)… SB-509 for Amyotrophic Lateral Sclerosis (ALS), SB-728-T for Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome (HIV / AIDS) and …
Around Broadneck: A fundraiser that raises funds while having fun – Annapolis Capital
Monday, November 29th, 2010Around Broadneck: A fundraiser that raises funds while having funAnnapolis CapitalThe formal name of this still incurable illness is amyotrophic lateral sclerosis, but it is better known as Lou Gehrig's Disease, named for the Yankee …
Two-year stimulus act funds 480 Johns Hopkins projects – The JHU Gazette
Monday, November 29th, 2010Two-year stimulus act funds 480 Johns Hopkins projectsThe JHU Gazette… stimulus grant from the NIH to expand on his long-standing research into the nerve- and muscle-wasting disease amyotrophic lateral sclerosis, or ALS. …and more »
« Previous Entries